We hypothesize that raised levels of circulating Hsp70 in higher tumor stages might support NK cell proliferation but that a lowered prevalence of CD4+ T helper cells tempers the capacity of cytolytic CD8+ T cells and NK cells to control tumor growth. The gene discussed is CD4; the disease is neoplasm.